乌头硷中毒致心律失常病例分析

分析了乌头硷类药物致心律失常的病例及治疗方法。     

高效液相色谱法测定血伤宁中的乌头碱含量

用ＨＰＬＣ法测定血伤宁中乌头碱的含量．在ＯＤＳ柱上,以甲醇（Ｖ）∶水（Ｖ）∶三乙胺（Ｖ）（７０∶３０∶０．１）作流动相,流速１．０ｍＬ／ｍｉｎ,检测波长为２４０ｎｍ,平均回收率９０．６０％,变异系数１．２５％．     

反相高效液相色谱法测定附子有效成分含量的方法研究

运用RP-HPLC测定不同地区附子药材中3种酯型生物碱———新乌头碱、乌头碱和次乌头碱的含量.实验以RP-C18色谱柱为固定相,乙腈-0.1%的乙二胺水溶液为流动相进行梯度洗脱.梯度洗脱程序:乙腈和0.1%的乙二胺水溶液的比率0~17 min为46∶54,17~37 min为82∶18;37~50 min为46∶54,流速为1.0mL/min;紫外检测波长为230 nm.新乌头碱、乌头碱和次乌头碱的标准曲线范围分别是5.62×10-6~5.062×10-5mol/L、2.614×10-6~2.614×10     

An interesting two‐phase solvent system and its use in preparative isolation of aconitines from aconite roots by counter‐current chromatography

Two‐phase solvent system plays crucial role in successful separation of organic compounds using counter‐current chromatography (CCC). An interesting two‐phase solvent system, composed of chloroform/ethyl acetate/methanol/water, is reported here, in which both phases contain sufficient organic solvents to balance their dissolving capacities. Adjusting the solvent system to get satisfactory partition coefficients (K values) for target compounds becomes relatively simple. This solvent system succeeded in sample preparation of aconitine (8.07 mg, 93.69%), hypaconitine (7.74 mg, 93.17%), mesaconitine (1.95 mg, 94.52%) from raw aconite roots (102.24 mg, crude extract), benzoylmesaconine (34.79 mg, 98.67%) from processed aconite roots (400.01 mg, crude extract), and yunaconitine (253.59 mg, 98.65%) from a crude extract of Aconitum forrestii (326.69 mg, crude extract).     

乌头碱的LC-MS定量分析

乌头生物碱各成分毒性差异很大,其中乌头碱的毒性为其它成分的100-2000倍,是引起中毒和死亡的主要原因。乌头生物碱种类多,在煎煮或泡制过程中易水解产生不同水解产物,进入体内后代谢情况又不明,因此采用液相色谱方法对体内检材乌头碱成分仅靠保留时间确定依据不足,定量工作更是无法开展。但在现实生活中炮制后的乌头植物可入药,且炮制过的乌头植物也可检出少量原碱。遇到体内检材中检验出乌头生物碱成分时,办案单位往往希望有一个量的甄别。经查阅资料,未见体内检材(如血、肝、尿等)中乌头碱含量的报道。我们应用LC-MS,采用646.4单离子扫描方式对实际案例血中乌头碱含量进行了测定,为今后的进一步研究和同行提供数据积累。     

HPLC测定蒙药清感九味丸中乌头碱的含量

目的：建立蒙药清感九味丸的质量标准．方法：用高效液相色谱法对处方中草乌有效成分乌头碱进行定量分析,采用VP-0D6（150L×4．6）柱;流动相为甲醇一水-氯仿-三乙胺（70：30：1：0．2V／V）;流速为0．5mL·min^-1;检测波长为240hm．结果：乌头碱进样量在0．60～3．Opg范围内与峰面积线性关系良好（r=0．9997）．平均加样回收率为99．28％（CV％=0．99％）．结论：本试验方法既先进又简便,结果准确可靠,可作为该制剂中乌头碱的含量测定方法．     

光度法测定尿液中乌头碱的含量

基于乌头碱在波长234 nm处有较好的吸收,建立了双光束紫外可见分光光度法测定尿液中乌头碱含量的方法.在优化的条件下,乌头碱的线性范围为0.645μg/mL~64.5μg/mL;检出限为5.66×10-8g/mL;相对标准偏差的平均值为0.13%.此方法用于测定尿液中乌头碱的含量,结果令人满意.     

利用软电离质谱技术研究乌头碱在肠内细菌中的生物转化

采用人肠内细菌和乌头碱温孵的方法及电喷雾质谱技术, 探讨了乌头碱在人肠内的生物转化规律. 根据在正离子电喷雾电离条件下乌头类生物碱质子化分子[M+H]+提供的分子量信息, 并结合精确质量测定提供的元素组成及串联质谱提供的结构信息, 可以对乌头碱的转化产物直接进行定性分析. 研究结果表明, 乌头碱在人肠内细菌环境中可通过脱乙酰基、脱甲基、脱羟基以及酯化反应产生新型的单酯型、双酯型和脂类生物.     

New understanding of aconitine hydrolysis pathway: Isolation,identification and toxicity evaluation based on intermediate products

Aconitine hydrolysis is deemed to be the guarantee for the safe application of Aconitum phytomedicine. Studies have suggested that hydrolysates of aconitine not only include benzoylaconitine and aconine, but other hydrolysates. Moreover, these hydrolysates maybe have a mutual transformation relationship, which has not been confirmed. Herein, hydrolysates of aconitine and their mutual transformation relationship were studied by the theoretical quantum chemistry, UPLC-Q-TOF-MS, the separation and identification of target products, etc. Then the toxicity of its hydrolysates was evaluated. The results demonstrate that the probability is the same for aconitine hydrolysis to pyroaconitine and benzoylaconitine, but they are difficult to convert to each other. Aconitine hydrolysis has three independent hydrolysis pathways, 1) to indaconitine, 2) to benzoylaconitine, and aconine, 3) to pyroaconitine and to 16-epi-pyroaconine. The result of embryotoxicity evaluation on zebrafish was aconitine > indaconitine > benzoylaconitine > α-pyroaconitine > β- pyroaconitine > aconine > 16-epi-pyroaconine. In conclusion, aconitine have three independent hydrolysis pathways and the hydrolysates of different pathways cannot be transformed into each other. Pyroaconitine is a hydrolysate of aconitine except for benzoylaconitine, and its toxicity is lower than benzoylaconitine. More importantly, it clarifies the long-standing debate and provides scientific evidence for the processing and detoxification of Aconitum phytomedicine.     

Four New Nor‐Diterpenoid Alkaloids from Aconitum brachypodum

Four new C₁₉‐nor‐diterpenoid alkaloids, named brachyaconitines A–D ( 1 – 4 ), were isolated from the roots of Aconitum brachypodum Diels. Their structures were elucidated as 3‐O‐acetyl‐20‐deethyl‐20‐formylaconitine ( 1 ), 3‐O‐acetyl‐19,20‐didehydro‐20‐deethylaconitine ( 2 ), 3‐O‐acetyl‐8‐de(acetyloxy)‐7,8,17,20‐tetradehydro‐20‐deethyl‐7,17‐secoaconitine ( 3 ), and 1‐O‐methylflavaconitine ( 4 ) by means of MS, IR, 1D‐ and 2D‐NMR analyses. The structure of compound 1 was confirmed by an X‐ray diffraction experiment.